Impact assessment was received by Parliament on Tuesday, 11 October 2005.
Full regulatory impact assessment for implementing the 2001 Review (consultation MLX 317) and other changes to UK medicines legislation. 8 p.
[Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005]
Secondary information
- Type
- Impact assessment
- Reference
- RIA 05/196;HINF 2005/1649
- Author
- Medicines and Healthcare products Regulatory Agency
- EC documents
- Dir2004/27/EC; Dir2001/83/EC; Reg(EC)726/2004
- Subjects
- Complementary medicine Licensing Liability Health hazards EU law Information Drugs Distribution Labelling Imports Medical treatments Patients Pharmacy Prescription drugs Packaging Monitoring Marketing Production Medical equipment Standards Regulation Safety Waste disposal Risk assessment Date marking
- Legislation
- Medicines Act 1968
- Medicines for Human Use (Manufacturing Wholesale Dealing and Miscellaneous Amendments) Regulations 2005
- Library location
- Commons Library: RIA 05/196
- Lords Library: HINF 2005/1649
Librarians' tools
- Timestamp
- 2023-11-18 15:23:37 +0000
- URI
- http://data.parliament.uk/pimsdata/ImpactAssessment/57323
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/ImpactAssessment/57323
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/ImpactAssessment/57323